Connection
Michaela Dolan to Imatinib Mesylate
This is a "connection" page, showing publications Michaela Dolan has written about Imatinib Mesylate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.031 |
|
|
|
-
O'Connell EM, Bennuru S, Steel C, Dolan MA, Nutman TB. Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal. J Infect Dis. 2015 Sep 01; 212(5):684-93.
Score: 0.031